Cannabidiol (CBD) has gained attention as a therapeutic agent and is purported to have
immunomodulatory, neuroprotective, and anti-seizure effects. Here, we determined the …

Cannabis sativa has been associated with contradictory effects upon seizure states despite
its medicinal use by numerous people with epilepsy. We have recently shown that the …

Cannabidiol (CBD) is a non-psychoactive phytocannabinoid known for its beneficial effects
including antioxidant and anti-inflammatory properties. Moreover, CBD is a compound with …

Cannabidiol (CBD) is a bioactive compound isolated from Cannabis plants that has
garnered attention within the medical community due to its potent anti-inflammatory …

Objective Epilepsy is a progressive neurological disease characterized by recurrent
seizures and behavioral comorbidities. We investigated the antiseizure effect of cannabidiol …

Epilepsy is a chronic neurological disease characterized by recurrent epileptic seizures.
Studies have shown the complexity of epileptogenesis and ictogenesis, in which …

Cannabidiol (CBD) is a phytocannabinoid with a broad-range of therapeutic potential in
several conditions, including neurological (epilepsy, neurodegenerative diseases, traumatic …

Epilepsy is a neurological disorder characterized by the presence of seizures and
neuropsychiatric comorbidities. Despite the number of antiepileptic drugs, one-third of …

Over the last several years, there has been increased interest in cannabidiol (CBD) to treat
various ailments such as pain, anxiety, insomnia, and inflammation. The potential for CBD …

Introduction: Cannabidiol (CBD) as Epidiolex®(GW Pharmaceuticals) was recently
approved by the US Food and Drug Administration (FDA) to treat rare forms of epilepsy in …